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TG level, Non-HDL-C, mg/dL 
mg/dL <100 100-129 130-159 160-189 190-219 220+ 
400-409 10.4 (9.1-12.5) 8.7 (7.6-10.2) 7.9 (6.9-9.1) 7.3 (6.4-8.4) 6.7 (5.9-7.7) 6.1 (5.1-6.9) 
410-419 10.7 (9.4-12.7) 8.9 (7.7-10.2) 7.9 (6.9-9.2) 7.3 (6.4-8.4) 6.7 (5.9-7.8) 6.0 (5.1-7.0) 
420-429 10.3 (9.2-13.7) 8.9 (7.8-10.4) 7.9 (6.9-9.2) 7.4 (6.3-8.4) 6.8 (5.9-7.7) 6.0 (5.1-7.0) 
430-439 11.2 (9.2-14.0) 8.9 (7.8-10.8) 8.0 (7.0-9.3) 7.3 (6.4-8.4) 6.8 (5.9-7.7) 6.0 (5.1-6.9) 
440-449 
12.0 (10.3-
13.9) 9.0 (8.0-10.5) 8.0 (7.0-9.3) 7.5 (6.3-8.6) 6.9 (5.9-7.9) 6.0 (5.1-7.1) 
450-459 11.3 (9.6-13.4) 9.3 (8.1-11.0) 8.2 (7.1-9.3) 7.4 (6.4-8.6) 7.0 (6.1-8.1) 6.0 (5.2-7.0) 
460-469 
12.3 (10.2-
14.2) 9.2 (8.0-10.9) 8.3 (7.2-9.6) 7.7 (6.5-8.8) 6.9 (5.9-7.9) 6.1 (5.1-7.1) 
470-479 10.6 (9.3-13.1) 9.3 (8.2-11.0) 8.3 (7.2-9.7) 7.6 (6.6-8.9) 7.0 (6.1-8.1) 6.0 (5.1-7.1) 
480-489 
11.7 (10.1-
15.6) 9.3 (8.3-10.9) 8.4 (7.3-9.8) 7.6 (6.7-8.9) 7.1 (6.1-8.2) 6.1 (5.2-7.2) 
490-499 
11.6 (10.7-
13.2) 9.6 (8.4-11.4) 8.4 (7.4-9.6) 7.6 (6.7-8.8) 7.2 (6.1-8.3) 6.2 (5.2-7.2) 
500-509 
12.1 (10.3-
14.8) 9.2 (8.2-10.8) 8.4 (7.4-10.0) 7.5 (6.6-8.8) 7.1 (6.1-8.2) 6.2 (5.2-7.2) 
510-519 
12.3 (10.7-
14.0) 9.9 (8.6-11.6) 8.5 (7.3-10.0) 7.9 (6.9-9.1) 7.1 (6.1-8.2) 6.3 (5.4-7.3) 
520-529 
12.0 (10.3-
15.9) 9.8 (8.6-12.0) 8.7 (7.6-10.2) 7.7 (6.7-8.9) 7.1 (6.3-8.3) 6.3 (5.3-7.3) 
530-539 12.0 (9.8-14.8) 9.8 (8.7-11.4) 8.7 (7.5-10.2) 7.8 (6.7-9.3) 7.2 (6.2-8.5) 6.3 (5.3-7.3) 
540-549 11.3 (9.8-14.4) 
10.0 (9.0-
















































































13.7) 9.5 (8.5-10.8) 8.5 (7.2-10.0) 7.8 (6.6-9.3) 6.9 (5.7-7.8) 















































19.4) 10.7 (9.1-13.4) 8.7 (7.9-9.7) 8.0 (7.0-9.0) 6.7 (5.8-7.8) 
 
 




level, Non-HDL-C, mg/dL 




























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Extended Martin/Hopkins LDL-C 
(40 TG, 6 Non-HDL categories; 240 
cells) Estimation (%) 
Extended Martin/Hopkins LDL-C 
(40 TG, 14 Non-HDL categories; 
560 cells) Estimation (%) 
Extended Martin/Hopkins 
LDL-C (40 TG, 26 Non-HDL 
categories; 1040 cells) 
Estimation (%) 
    <40 40.1 57.2 59.9 60.2 
    40-69 66.4 67.8 69.0 68.2 
    70-99 65.7 65.2 65.5 65.0 
    100-129  61.0 60.7 60.8 60.6 
    130-159 57.2 58.5 58.4 58.1 
    160-189 53.3 56.0 56.0 56.0 
    ≥190 65.3 70.1 70.1 70.1 
Overall 61.0 62.1 62.3 62.0 
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eTable 3. Percentage of patients by absolute error between estimated LDL-C and direct LDL-C for TG 400-799 mg/dL 
 
Estimated LDL-C (mg/dL) <5 mg/dL error 5-9 mg/dL error 10-19 mg/dL error 
20-29 mg/dL error 
≥30 mg/dL error 
    Extended LDL-C: <401 
32.6 (25.9-40.0) 31.4 (24.9-38.8) 26.7 (20.6-33.9) 6.4 (3.6-11.2) 2.9 (1.2-6.8) 
    Extended LDL-C: <402 33.0 (26.4-40.3) 31.2 (24.8-38.5) 26.1 (20.1-33.2) 6.8 (3.9-11.7) 2.8 (1.2-6.7) 
    Extended LDL-C: 40-691 34.2 (32.6-35.9) 26.0 (24.5-27.6) 30.1 (28.5-31.7) 7.9 (7.0-8.9) 1.8 (1.4-2.3) 
    Extended LDL-C: 40-692 33.3 (31.6-34.9) 26.8 (25.3-28.4) 30.2 (28.7-31.9) 7.7 (6.8-8.7) 2.0 (1.6-2.6) 
    Extended LDL-C: 70-991 30.4 (29.4-31.3) 25.6 (24.7-26.5) 30.3 (29.4-31.3) 10.5 (9.9-11.1) 3.3 (2.9-3.6) 
    Extended LDL-C: 70-992 30.3 (29.4-31.2) 25.3 (24.5-26.2) 30.0 (29.1-31.0) 10.8 (10.2-11.4) 3.6 (3.2-4.0) 
    Extended LDL-C: 100-1291 27.4 (26.6-28.2) 24.1 (23.4-24.9) 30.4 (29.6-31.3) 12.0 (11.4-12.6) 6.0 (5.6-6.5) 
    Extended LDL-C: 100-1292 27.0 (26.2-27.8) 24.3 (23.6-25.1) 30.5 (29.7-31.3) 12.0 (11.4-12.6) 6.2 (5.7-6.6) 
    Extended LDL-C: 130-1591 24.8 (23.8-25.7) 21.9 (21.0-22.8) 31.1 (30.1-32.1) 13.6 (12.8-14.4) 8.7 (8.1-9.3) 
    Extended LDL-C: 130-1592 24.8 (23.9-25.8) 21.9 (21.0-22.8) 31.0 (30.0-32.0) 13.7 (13.0-14.5) 8.6 (8.0-9.3) 
    Extended LDL-C: 160-1891 22.6 (21.1-24.1) 20.5 (19.0-22.0) 29.8 (28.2-31.5) 13.8 (12.6-15.1) 13.3 (12.1-14.6) 
    Extended LDL-C: 160-1892 22.6 (21.1-24.1) 20.5 (19.0-22.0) 29.8 (28.2-31.5) 13.8 (12.6-15.1) 13.3 (12.1-14.6) 
    Extended LDL-C: ≥1901 18.4 (16.8-20.1) 17.2 (15.7-18.9) 25.6 (23.8-27.4) 14.1 (12.7-15.7) 24.7 (22.9-26.5) 
    Extended LDL-C: ≥1902 18.4 (16.8-20.1) 17.2 (15.7-18.9) 25.6 (23.8-27.4) 14.1 (12.7-15.7) 24.7 (22.9-26.5) 
 
1 14 non-HDL-C categories 
2  26 non-HDL-C categories 
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eTable 4. Median difference between estimated and direct VLDL-C by TG and Non-HDL-C Strata   
 













Triglyceride, mg/dL Friedewald  Sampson Martin/Hopkins  Extended Martin/Hopkins  
    400-499 28.0 (16.4-37.6) 14.7 (5.6-22.9) -5.1 (-14.6-3.0) 0.1 (-9.3-8.2) 
    500-599 37.6 (23.8-49.6) 19.0 (8.1-29.1) -2.2 (-13.5-7.9) -0.0 (-11.1-10.2) 
    600-699 48.2 (31.4-62.2) 23.0 (10.4-34.7) 1.2 (-11.8-13.3) -0.1 (-13.2-11.8) 
    700-799 60.1 (41.8-76.0) 26.8 (14.2-39.7) 6.7 (-6.6-19.5) 0.4 (-12.6-13.6) 
Overall 33.0 (20.0-46.0) 17.1 (6.9-26.7) -3.3 (-13.7-6.2) 0.1 (-10.4-9.3) 
© 2021 Sajja A et al. JAMA Network Open. 
 
 
B. Non-HDL-C strata, median (IQR) mg/dL 
 
Non-HDL-C, mg/dL Friedewald  Sampson Martin/Hopkins Extended Martin/Hopkins 
    <100 57.0 (45.8-73.4) 20.5 (13.4-29.5) 0.4 (-7.3-9.4) -0.1 (-7.0-7.7) 
    100-129 46.6 (36.4-59.6) 17.2 (9.4-25.2) -1.6 (-9.3-6.9) 0.5 (-7.1-8.3) 
    130-159 40.0 (30.4-52.0) 16.4 (7.8-24.7) -1.6 (-10.4-6.6) 0.5 (-8.2-8.5) 
    160-189 34.2 (24.0-45.8) 16.3 (6.9-25.4) -3.3 (-12.8-5.7) -0.1 (-9.9-8.5) 
    190-219 29.2 (17.8-41.6) 17.6 (6.3-27.4) -3.5 (-14.7-6.3) 0.1 (-11.2-9.6) 
    220+ 18.8 (3.8-32.2) 18.0 (4.0-30.0) -6.5 (-21.7-5.6) -0.4 (-15.8-11.7) 









eTable 5. Relative Difference Between Estimated and Direct VLDL-C by TG and Non-HDL-C Strata   
 
A. TG strata, median (IQR), % 
   
Triglyceride, mg/dL Friedewald  Sampson Martin/Hopkins  Extended Martin/Hopkins  
    400-499 46.4 (23.1-73.7) 24.7 (8.1-44.1) -8.5 (-21.0-5.9) 0.2 (-13.4-15.9) 
    500-599 53.3 (28.3-84.0) 27.0 (9.8-48.5) -3.2 (-16.5-13.2) -0.0 (-13.6-17.0) 
    600-699 60.3 (32.5-92.8) 28.7 (11.2-50.7) 1.5 (-12.6-19.6) -0.2 (-14.5-17.2) 
    700-799 67.7 (39.0-104.1) 31.2 (13.8-53.0) 7.6 (-6.6-26.3) 0.5 (-12.9-18.3) 
Overall 51.0 (26.2-80.6) 26.1 (9.2-46.4) -5.0 (-18.3-10.8) 0.1 (-13.5-16.5) 




B. Non-HDL-C strata, median (IQR), % 
 
Non-HDL-C, mg/dL Friedewald Sampson Martin/Hopkins  Extended Martin/Hopkins  
    <100 140.5 (101.8-203.3) 49.9 (27.8-84.6) 1.1 (-15.2-27.5) -0.2 (-14.8-21.9) 
    100-129 93.8 (67.1-130.6) 33.5 (16.4-56.9) -3.1 (-16.5-15.3) 0.9 (-12.0-19.7) 
    130-159 70.9 (47.9-98.8) 28.5 (11.9-48.5) -2.9 (-16.0-13.0) 0.8 (-12.2-16.8) 
    160-189 53.8 (33.4-78.3) 25.4 (9.4-45.2) -5.1 (-17.6-10.1) -0.2 (-13.1-15.4) 
    190-219 42.5 (22.4-65.2) 25.1 (7.9-44.1) -5.0 (-18.4-10.2) 0.1 (-13.6-15.7) 
    220+ 23.3 (4.0-44.7) 21.9 (4.2-41.8) -8.0 (-22.4-8.0) -0.6 (-15.8-16.7) 
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